Table 2 The clinical, biochemical and laboratory data of 60 patients
Characterize | Control | Patients | P |
|---|---|---|---|
Gender (M/F) | 3/4 | 25/28 | > 0.05 |
Age (years) | 29.2 ± 9.9 | 30.1 ± 10.2 | > 0.05 |
Liver inflammation (G :1/2/3/4) | 5/2/0/0 | 4/16/23/10 | |
Liver fibrosis (S: 1/2/3/4) | 4/3/0/0 | 6/18/20/9 | |
ALT (IU/l) | 21.2 ± 10.2 | 64 ± 21.1 | < 0.05 |
AST (IU/l) | 18.8 ± 8.3 | 51.3 ± 9.8 | < 0.05 |
Total bilirubin (μmol/l) | 7.2 ± 2.3 | 27.8 ± 11.1 | < 0.05 |
Albumin (g/l) | 48.1 ± 15.3 | 36.3 ± 12.6 | < 0.05 |
HBV DNA (log copy/ml) | 0 | 4.7 ± 1.5 | < 0.05 |